FDAClass IIISeptember 3, 2014

Diltiazem HCl Extended Release Capsules recall: Impurity Out of Spec

Diltiazem HCl Extended Release Capsules, USP 120 mg, 500 count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505. NDC 0378-5220-05.

Why was Diltiazem HCl Extended Release Capsules recalled?

Failed Impurities/Degradation Specifications: High out-of-specification results for a related compound obtained during routine stability testing.

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot 3040063 Exp. 07/14

Product
Diltiazem HCl Extended Release Capsules, USP 120 mg, 500 count bottles, Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505. NDC 0378-5220-05.
Recalling firm
Mylan Pharmaceuticals Inc.
Quantity
2,658 Bottles
Distribution
Nationwide
Recall date
September 3, 2014
Classification
Class III
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls